- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
NeuroBo Pharmaceuticals (NASDAQ:NRBO), Quotes and News Summary
NeuroBo Pharmaceuticals (NASDAQ: NRBO)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-15 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.110 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
NeuroBo Pharmaceuticals Questions & Answers
You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ: NRBO) through any online brokerage.
Other companies in NeuroBo Pharmaceuticals’s space includes: Immuron (NASDAQ:IMRN), Addex Therapeutics (NASDAQ:ADXN), Midatech Pharma (NASDAQ:MTP), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and BioRestorative Therapies (NASDAQ:BRTX).
The latest price target for NeuroBo Pharmaceuticals (NASDAQ: NRBO) was reported by HC Wainwright & Co. on Monday, February 1, 2021. The analyst firm set a price target for 16.00 expecting NRBO to rise to within 12 months (a possible 3420.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $0.4545 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for NeuroBo Pharmaceuticals.
NeuroBo Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for NeuroBo Pharmaceuticals.
NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.